RARRES2 and Insulin resistance: Elevated chemerin levels are linked to metabolic syndrome [51], insulin resistance [52], and lipid metabolic dysfunction by impacting signalling pathways like ERK [53], underscoring its role as a potential risk factor for atherosclerosis and metabolic imbalance [54].